Cracking the Code: Essential Hematology Concepts for Your FNP Boards
Hematology · 5 min read · July 11, 2026
Cracking the Code: Essential Hematology Concepts for the FNP Board Exam
Hematology can feel overwhelming because it involves unfamiliar laboratory values, overlapping symptoms, and long lists of possible diagnoses. Fortunately, most hematology questions on the AANP and ANCC Family Nurse Practitioner board exams are not asking you to diagnose a rare bone marrow disorder.
Instead, they typically test whether you can:
- Recognize common patterns on a complete blood count
- Classify anemia according to red blood cell size
- Differentiate iron, vitamin B12, and folate deficiencies
- Identify dangerous bleeding findings
- Interpret platelet and coagulation studies
- Determine when a patient needs further evaluation or urgent referral
The secret is to stop memorizing isolated laboratory values and begin recognizing patterns.
This guide walks you through the hematology concepts every FNP student should know before exam day.
Start Here: What Is Anemia?
Anemia occurs when the blood does not contain enough functional red blood cells or hemoglobin to adequately deliver oxygen to the body’s tissues.
Common symptoms include:
- Fatigue
- Weakness
- Pallor
- Dyspnea on exertion
- Dizziness
- Headache
- Exercise intolerance
- Palpitations
- Tachycardia
Severe or rapidly developing anemia may produce chest pain, syncope, hypotension, heart failure symptoms, or evidence of tissue hypoxia.
However, symptoms alone rarely identify the cause. The first major clue is usually the mean corpuscular volume, or MCV.
The First Step in Any Anemia Question: Look at the MCV
The MCV tells you the average size of the patient’s red blood cells.
| MCV |
Classification |
Common Causes |
| Less than 80 fL |
Microcytic anemia |
Iron deficiency, thalassemia, anemia of chronic inflammation, sideroblastic anemia |
| 80–100 fL |
Normocytic anemia |
Acute blood loss, chronic kidney disease, hemolysis, anemia of chronic disease, early iron deficiency |
| Greater than 100 fL |
Macrocytic anemia |
Vitamin B12 deficiency, folate deficiency, alcohol use, liver disease, hypothyroidism, certain medications |
Board-Exam Strategy
When you see anemia:
- Confirm that the hemoglobin and hematocrit are low.
- Look at the MCV.
- Use the MCV to narrow the differential diagnosis.
- Examine the reticulocyte count, iron studies, vitamin levels, symptoms, and clinical history.
- Identify the underlying cause—not merely the type of anemia.
A common board-exam mistake is assuming that all iron-deficiency anemia is microcytic. Early iron deficiency may still be normocytic. Microcytosis generally becomes more apparent as the deficiency progresses.
The Three Nutritional Anemias You Must Know
1. Iron-Deficiency Anemia
Iron-deficiency anemia is one of the most common anemia patterns encountered in primary care and is a major board-exam topic.
Iron is required to produce hemoglobin. When iron stores are depleted, the bone marrow cannot produce adequately hemoglobinized red blood cells.
Common Causes
Think about three major mechanisms:
Blood Loss
- Heavy or prolonged menstrual bleeding
- Gastrointestinal bleeding
- Peptic ulcer disease
- Colorectal polyps or malignancy
- Inflammatory bowel disease
- Frequent blood donation
- Postoperative blood loss
- Chronic use of medications that increase gastrointestinal bleeding risk
Inadequate Intake
- Restrictive diets
- Malnutrition
- Limited consumption of iron-rich foods
- Increased nutritional needs without adequate replacement
Impaired Absorption or Increased Demand
- Celiac disease
- Inflammatory bowel disease
- Bariatric or gastric surgery
- Pregnancy
- Rapid growth during childhood or adolescence
Typical Laboratory Pattern
| Test |
Iron-Deficiency Anemia |
| Hemoglobin and hematocrit |
Decreased |
| MCV |
Decreased, although it may be normal early |
| Ferritin |
Decreased |
| Serum iron |
Decreased |
| TIBC or transferrin |
Increased |
| Transferrin saturation |
Decreased |
| RDW |
Often increased |
| Reticulocyte count |
Usually low or inappropriately normal before treatment |
Why Does TIBC Increase?
Transferrin is the major iron-transport protein. When circulating iron is low, the liver generally produces more transferrin in an attempt to capture available iron.
Therefore:
- Less iron is available
- More binding capacity is available
- Transferrin saturation falls
This produces the classic pattern:
Low iron + low ferritin + high TIBC + low transferrin saturation
Ferritin: The Most Important Iron-Storage Marker
Ferritin reflects stored iron. A clearly low ferritin level strongly supports iron deficiency.
However, ferritin is also an acute-phase reactant. It may be normal or elevated in patients with inflammation, infection, liver disease, malignancy, or chronic illness—even when iron deficiency is present. In these cases, ferritin should be interpreted alongside the transferrin saturation and the patient’s overall clinical picture.
Clinical Manifestations
In addition to general anemia symptoms, iron deficiency may produce:
- Pica
- Pagophagia, or compulsive ice chewing
- Glossitis
- Angular cheilitis
- Brittle nails
- Koilonychia, or spoon-shaped nails
- Restless legs
- Headaches
- Reduced exercise tolerance
- Cognitive or concentration difficulties
Treatment
Oral iron is commonly used as initial therapy when absorption is expected to be adequate and the patient can tolerate it.
Patient education may include:
- Take iron as directed.
- Vitamin C or a vitamin C–containing beverage may improve absorption.
- Avoid taking iron at the same time as calcium, antacids, tea, or coffee because they may impair absorption.
- Gastrointestinal upset, constipation, nausea, and dark stools may occur.
- Taking iron with food may improve tolerance, although it may decrease absorption.
- Keep iron supplements out of the reach of children because overdose can be fatal.
Intravenous iron may be considered when the patient:
- Cannot tolerate oral therapy
- Has impaired gastrointestinal absorption
- Has ongoing substantial blood loss
- Requires more rapid replacement
- Has failed an adequate trial of oral therapy
- Has certain chronic inflammatory or kidney conditions
The Most Important Clinical Pearl
Iron deficiency is a diagnosis and a clue.
Do not simply prescribe iron and stop the evaluation. Determine why the patient became iron deficient.
Unexplained iron-deficiency anemia in an adult man or a postmenopausal woman should raise concern for occult gastrointestinal blood loss and may require gastrointestinal evaluation. Premenopausal women may also require further evaluation when menstrual loss does not adequately explain the severity of the anemia, when gastrointestinal symptoms are present, or when treatment response is inadequate. Underlying gastrointestinal disease, including malignancy, must not be overlooked.
Board Buzzwords
- Pica
- Ice chewing
- Koilonychia
- Low ferritin
- High TIBC
- Low transferrin saturation
- Chronic blood loss
- Microcytic, hypochromic red blood cells
2. Vitamin B12 Deficiency
Vitamin B12 deficiency classically causes a megaloblastic macrocytic anemia, but patients can develop neurologic manifestations even before anemia or macrocytosis becomes obvious.
Vitamin B12 is necessary for normal DNA synthesis and neurologic function.
Common Causes
- Pernicious anemia
- Autoimmune destruction of gastric parietal cells
- Lack of intrinsic factor
- Gastric bypass or other gastric surgery
- Terminal ileal disease or resection
- Crohn disease involving the terminal ileum
- Strict vegan diet without supplementation
- Long-term use of certain medications associated with impaired B12 absorption
- Older age and food-bound B12 malabsorption
- Other gastrointestinal malabsorption disorders
Pernicious Anemia Is Not a Synonym for Every B12 Deficiency
This distinction is important.
Vitamin B12 deficiency refers to an insufficient amount of vitamin B12 from any cause.
Pernicious anemia is an autoimmune disorder that causes vitamin B12 deficiency because the patient cannot produce or effectively use adequate intrinsic factor for absorption.
Intrinsic factor is produced by gastric parietal cells. Vitamin B12 binds to intrinsic factor and is subsequently absorbed in the terminal ileum.
Typical Laboratory Pattern
| Test |
Vitamin B12 Deficiency |
| Hemoglobin and hematocrit |
Decreased |
| MCV |
Usually increased |
| Vitamin B12 level |
Decreased or borderline |
| Methylmalonic acid |
Increased |
| Homocysteine |
Increased |
| Peripheral smear |
Macro-ovalocytes and hypersegmented neutrophils |
| Reticulocyte count |
Usually low before treatment |
Both methylmalonic acid and homocysteine typically rise in vitamin B12 deficiency. These tests are particularly useful when the serum B12 level is borderline or does not match the clinical presentation. Renal impairment can also elevate methylmalonic acid, so the result must be interpreted in context.
Neurologic Manifestations
Vitamin B12 deficiency can produce:
- Numbness or tingling
- Peripheral neuropathy
- Loss of vibration sensation
- Impaired proprioception
- Gait instability
- Ataxia
- Muscle weakness
- Cognitive changes
- Memory impairment
- Irritability
- Depression or other neuropsychiatric manifestations
Severe deficiency may cause subacute combined degeneration involving the posterior and lateral columns of the spinal cord.
Neurologic symptoms can occur even without severe anemia and may become irreversible when diagnosis and treatment are delayed.
Diagnosis of Pernicious Anemia
Testing may include:
- Anti-intrinsic factor antibodies
- Antiparietal cell antibodies
- Serum vitamin B12
- Methylmalonic acid
- Homocysteine
- CBC and peripheral smear
Anti-intrinsic factor antibodies are more specific for pernicious anemia, although a negative test does not completely exclude the condition.
Treatment
Treatment depends on severity, symptoms, cause, and the patient’s ability to absorb vitamin B12.
Options include:
- Intramuscular vitamin B12
- High-dose oral vitamin B12
- Intranasal preparations in selected maintenance situations
Parenteral replacement is often preferred when the patient has severe deficiency, significant neurologic symptoms, or substantial malabsorption. Patients with an irreversible cause, such as pernicious anemia or permanent gastrointestinal malabsorption, generally require lifelong replacement.
Critical Safety Rule
Do not treat an undiagnosed macrocytic anemia with folic acid alone until vitamin B12 deficiency has been excluded.
Folate may improve the hematologic abnormalities while the underlying vitamin B12–related neurologic injury continues.
Board Buzzwords
- Macrocytic anemia
- Hypersegmented neutrophils
- Macro-ovalocytes
- Peripheral neuropathy
- Loss of vibration or position sense
- Elevated methylmalonic acid
- Elevated homocysteine
- Pernicious anemia
- Lack of intrinsic factor
- Terminal ileum
3. Folate-Deficiency Anemia
Folate deficiency also causes a megaloblastic macrocytic anemia. Its hematologic appearance can be almost identical to vitamin B12 deficiency.
The most important traditional distinction is that isolated folate deficiency does not cause the characteristic neurologic deficits seen with vitamin B12 deficiency.
Common Causes
- Poor dietary intake
- Alcohol use disorder
- Malnutrition
- Malabsorption
- Pregnancy
- Increased cell turnover
- Hemolytic disorders
- Dialysis
- Medications that interfere with folate metabolism
Medication-related causes may include:
- Methotrexate
- Trimethoprim
- Pyrimethamine
- Certain antiseizure medications
- Sulfasalazine
Typical Laboratory Pattern
| Test |
Folate Deficiency |
| Hemoglobin and hematocrit |
Decreased |
| MCV |
Increased |
| Folate level |
Decreased |
| Homocysteine |
Increased |
| Methylmalonic acid |
Normal |
| Peripheral smear |
Macro-ovalocytes and hypersegmented neutrophils |
| Neurologic deficits |
Characteristically absent |
Symptoms
- Fatigue
- Pallor
- Weakness
- Glossitis
- Reduced exercise tolerance
- Other nonspecific manifestations of anemia
Treatment
Treatment generally involves oral folic acid and correction of the underlying cause.
Before beginning folate replacement, evaluate for concurrent vitamin B12 deficiency, especially when macrocytosis, malnutrition, neurologic symptoms, gastrointestinal disease, or an unclear dietary history is present.
Pregnancy Connection
Adequate folic acid intake before conception and during early pregnancy reduces the risk of fetal neural tube defects. Patients capable of becoming pregnant should receive appropriate preconception counseling and supplementation based on their risk factors.
Board Buzzwords
- Macrocytic anemia
- Alcohol use disorder
- Pregnancy
- Poor nutrition
- Hypersegmented neutrophils
- Elevated homocysteine
- Normal methylmalonic acid
- No characteristic neurologic deficits
Vitamin B12 Deficiency vs. Folate Deficiency
| Feature |
Vitamin B12 Deficiency |
Folate Deficiency |
| MCV |
Increased |
Increased |
| Megaloblastic changes |
Present |
Present |
| Hypersegmented neutrophils |
Present |
Present |
| Homocysteine |
Increased |
Increased |
| Methylmalonic acid |
Increased |
Normal |
| Neurologic manifestations |
May be present |
Characteristically absent |
| Common association |
Pernicious anemia, gastric surgery, terminal ileal disease |
Alcohol use, poor intake, pregnancy, medications |
| Major safety concern |
Neurologic injury may become irreversible |
Exclude B12 deficiency before giving folate alone |
Memory Trick
B12 affects the blood and the brain.
For laboratory differentiation:
- B12 deficiency: Homocysteine up, MMA up
- Folate deficiency: Homocysteine up, MMA normal
A Fourth Anemia Pattern Worth Knowing: Anemia of Chronic Inflammation
Although iron, B12, and folate deficiencies receive significant attention, board questions may also test anemia associated with chronic inflammation.
Potential underlying conditions include:
- Chronic infection
- Autoimmune or inflammatory disease
- Malignancy
- Chronic kidney disease
- Other chronic systemic illnesses
Inflammation increases hepcidin activity. Hepcidin reduces intestinal iron absorption and traps iron within storage cells, making less iron available for red blood cell production.
Typical Laboratory Pattern
| Test |
Anemia of Chronic Inflammation |
| Serum iron |
Decreased |
| Ferritin |
Normal or increased |
| TIBC |
Decreased or normal |
| Transferrin saturation |
Decreased |
| MCV |
Usually normocytic; may become microcytic |
| RDW |
Often normal or mildly increased |
The Key Comparison
Iron-Deficiency Anemia
- Low iron
- Low ferritin
- High TIBC
Anemia of Chronic Inflammation
- Low iron
- Normal or high ferritin
- Low or normal TIBC
This is one of the most frequently tested iron-study comparisons.
Do Not Forget the Reticulocyte Count
Reticulocytes are immature red blood cells. The reticulocyte count helps determine whether the bone marrow is responding appropriately to anemia.
Increased Reticulocyte Count
Think:
- Hemolysis
- Acute blood loss
- Recovery after treatment
The marrow is attempting to replace red blood cells that have been lost or destroyed.
Low or Inappropriately Normal Reticulocyte Count
Think:
- Iron deficiency
- Vitamin B12 deficiency
- Folate deficiency
- Bone marrow suppression
- Chronic kidney disease
- Anemia of chronic inflammation
The marrow is not producing enough new red blood cells relative to the degree of anemia.
Board-Exam Question
A patient has anemia and an elevated reticulocyte count. Which process is most likely?
Think blood loss or red blood cell destruction, not inadequate substrate production.
Platelet Disorders: Recognizing Thrombocytopenia
Platelets are essential for primary hemostasis. A low platelet count increases the risk of bleeding, particularly mucocutaneous bleeding.
Common Manifestations of Thrombocytopenia
- Petechiae
- Purpura
- Easy bruising
- Epistaxis
- Gingival bleeding
- Heavy menstrual bleeding
- Prolonged bleeding after minor trauma
- Hematuria or gastrointestinal bleeding in more severe cases
Platelet disorders generally cause mucosal and superficial bleeding, while coagulation-factor disorders more commonly cause deep-tissue bleeding, hemarthroses, and large hematomas.
Immune Thrombocytopenia
The preferred name is immune thrombocytopenia, although the older term “idiopathic thrombocytopenic purpura” may still appear in review materials and clinical conversations.
ITP is an acquired autoimmune disorder in which antibodies contribute to platelet destruction and may also impair platelet production.
Common Presentations
Children
- Often follows a viral illness
- May be abrupt in onset
- Frequently resolves spontaneously
- Treatment is guided more by bleeding severity than by the platelet number alone
Adults
- More likely to follow a chronic or relapsing course
- May be primary or associated with another condition
- Requires evaluation for secondary causes
Typical Findings
- Isolated thrombocytopenia
- Otherwise relatively normal CBC
- Petechiae or purpura
- Easy bruising
- Epistaxis or gingival bleeding
- Normal PT and aPTT
- No alternative explanation for the thrombocytopenia
Marked splenomegaly, lymphadenopathy, major abnormalities in other blood cell lines, or systemic illness should prompt consideration of another diagnosis.
Diagnosis
ITP is a diagnosis of exclusion.
The evaluation may include:
- Repeat CBC
- Peripheral blood smear
- Medication review
- Pregnancy testing when appropriate
- Liver and renal assessment when indicated
- Testing for infections or autoimmune disease based on risk factors
- Evaluation for other causes of thrombocytopenia
The peripheral smear is particularly important because platelet clumping can create pseudothrombocytopenia, a falsely low automated platelet count.
Treatment
Management depends on:
- Platelet count
- Degree of bleeding
- Age
- Comorbidities
- Anticoagulant or antiplatelet use
- Planned procedures
- Likelihood of follow-up
- Overall diagnostic certainty
Observation may be appropriate for patients with mild or no bleeding and an acceptable platelet count.
When treatment is required, initial options may include:
- Corticosteroids
- Intravenous immune globulin
- Anti-D immune globulin in selected patients
Persistent or refractory disease may require:
- Thrombopoietin receptor agonists
- Rituximab
- Splenectomy
- Other specialist-directed therapy
Current hematology guidance favors a short course of corticosteroids rather than prolonged prednisone exposure when steroids are used for newly diagnosed adult ITP.
When Is Thrombocytopenia an Emergency?
There is no single platelet number that determines urgency in every patient. Clinical context and active bleeding matter.
Urgent or emergency evaluation is warranted when thrombocytopenia is accompanied by:
- Active major bleeding
- Neurologic symptoms
- Severe headache or altered mental status
- Suspected intracranial hemorrhage
- Hemodynamic instability
- Gastrointestinal bleeding
- Hematuria with significant blood loss
- Pregnancy-related hypertension or hemolysis
- Fever, renal dysfunction, neurologic abnormalities, or evidence of microangiopathic hemolysis
- A rapidly falling platelet count
- An extremely low platelet count, particularly around or below 10,000/µL
Patients with counts below approximately 20,000/µL commonly require urgent assessment, especially when bleeding, additional risk factors, or diagnostic uncertainty is present. However, the disposition should not be based on the platelet count alone.
Board Pearl
ITP typically produces:
Low platelets + normal PT + normal aPTT
If PT and aPTT are both prolonged in a critically ill or bleeding patient, think beyond isolated ITP.
Dangerous Thrombocytopenia Mimics
Not every low platelet count is ITP.
Thrombotic Thrombocytopenic Purpura
TTP is a hematologic emergency involving severe ADAMTS13 deficiency and microvascular platelet-rich thrombi.
Look for:
- Thrombocytopenia
- Microangiopathic hemolytic anemia
- Schistocytes
- Neurologic changes
- Renal dysfunction
- Fever, although the complete classic pentad is often absent
A patient with thrombocytopenia, anemia, schistocytes, elevated lactate dehydrogenase, and neurologic or renal abnormalities needs emergency evaluation.
Disseminated Intravascular Coagulation
DIC involves widespread activation and consumption of coagulation factors and platelets.
Possible findings include:
- Thrombocytopenia
- Prolonged PT
- Prolonged aPTT
- Elevated D-dimer
- Reduced fibrinogen
- Bleeding and thrombosis
- Severe underlying illness such as sepsis, trauma, malignancy, or obstetric catastrophe
Heparin-Induced Thrombocytopenia
Think about HIT when:
- The patient recently received heparin
- The platelet count falls significantly, often by more than 50% from baseline
- The decline occurs in a compatible timeframe
- New thrombosis develops
HIT is primarily a prothrombotic disorder, even though the platelet count is low.
The immediate concern is thrombosis—not simply bleeding.
PT, INR, and aPTT: What Do They Actually Measure?
Prothrombin Time and INR
PT evaluates the extrinsic and common coagulation pathways.
It is commonly associated with:
- Warfarin monitoring
- Vitamin K deficiency
- Liver dysfunction
- Factor VII abnormalities
- DIC
The INR standardizes the PT result between laboratories.
Common Board Association
Warfarin → monitor PT/INR
A typical target INR for many indications is 2.0–3.0. Certain patients, such as those with specific mechanical heart valves, may require a different target.
Activated Partial Thromboplastin Time
The aPTT evaluates the intrinsic and common coagulation pathways.
It is commonly associated with:
- Unfractionated heparin monitoring
- Hemophilia
- Certain factor deficiencies
- Lupus anticoagulant
- DIC
Common Board Association
Unfractionated heparin → monitor aPTT or an institution-specific anti-Xa level
Low-molecular-weight heparins are not routinely monitored using the aPTT.
High-Yield Coagulation Patterns
| Disorder or Therapy |
PT/INR |
aPTT |
Platelets |
| Warfarin therapy |
Increased |
Usually normal or mildly increased |
Usually normal |
| Unfractionated heparin therapy |
Usually normal |
Increased |
Usually normal unless HIT develops |
| Hemophilia |
Normal |
Increased |
Normal |
| Vitamin K deficiency |
Increased first; may prolong further with severity |
May increase when severe |
Usually normal |
| ITP |
Normal |
Normal |
Decreased |
| DIC |
Increased |
Increased |
Decreased |
| von Willebrand disease |
Usually normal |
Normal or sometimes mildly increased |
Usually normal |
Essential Hematology Values
Reference ranges vary slightly among laboratories. On an exam, use the range supplied with the question whenever one is provided.
Hemoglobin
Approximate adult reference ranges:
- Men: about 13.5–17.5 g/dL
- Women: about 12.0–15.5 g/dL
Interpret hemoglobin in the context of age, pregnancy status, altitude, hydration, laboratory standards, symptoms, and comorbidities.
Hematocrit
Approximate adult reference ranges:
- Men: about 41%–53%
- Women: about 36%–46%
The hematocrit is often approximately three times the hemoglobin, but this is only an estimate and may not hold in all clinical situations.
MCV
- Less than 80 fL: Microcytic
- 80–100 fL: Normocytic
- Greater than 100 fL: Macrocytic
RDW
The red cell distribution width reflects variation in red blood cell size.
An increased RDW suggests greater variation in cell size, known as anisocytosis.
It is commonly elevated in iron-deficiency anemia because newly produced cells become progressively smaller as the deficiency worsens.
Platelet Count
Typical reference range:
- Approximately 150,000–450,000/µL
Definitions:
- Below 150,000/µL: Thrombocytopenia
- Above 450,000/µL: Thrombocytosis
Always interpret the platelet count according to the patient’s symptoms, trend, medications, underlying diseases, and bleeding risk.
White Blood Cell Count
A typical adult range is approximately:
Important differential terms include:
- Neutrophilia: Often associated with bacterial infection, inflammation, stress, or corticosteroid use
- Lymphocytosis: Often associated with viral infection
- Eosinophilia: May occur with allergic disease, parasitic infection, or medication reactions
- Neutropenia: Raises concern for infection risk, especially when severe
A Practical Anemia Comparison Table
| Feature |
Iron Deficiency |
Anemia of Chronic Inflammation |
Vitamin B12 Deficiency |
Folate Deficiency |
| MCV |
Low; may be normal early |
Usually normal; sometimes low |
High |
High |
| Ferritin |
Low |
Normal or high |
Usually normal |
Usually normal |
| Serum iron |
Low |
Low |
Not diagnostic |
Not diagnostic |
| TIBC |
High |
Low or normal |
Not diagnostic |
Not diagnostic |
| Transferrin saturation |
Low |
Low |
Not diagnostic |
Not diagnostic |
| Homocysteine |
Usually normal |
Usually normal |
High |
High |
| MMA |
Normal |
Normal |
High |
Normal |
| Neurologic findings |
No characteristic deficit |
No characteristic deficit |
May be present |
Characteristically absent |
| Classic clue |
Pica or chronic blood loss |
Chronic inflammatory disease |
Neuropathy or pernicious anemia |
Alcohol use, pregnancy, poor intake |
How Board Questions Commonly Present Hematology
Pattern 1: Microcytic Anemia With Pica
A menstruating patient reports fatigue and compulsive ice chewing. Laboratory studies show low hemoglobin, low MCV, low ferritin, and elevated TIBC.
Most likely diagnosis: Iron-deficiency anemia
The next step is not simply to prescribe iron. Evaluate the source of iron loss.
Pattern 2: Macrocytosis With Neuropathy
An older adult presents with fatigue, gait instability, and numbness in both feet. Laboratory studies show an elevated MCV and low vitamin B12 level.
Most likely diagnosis: Vitamin B12 deficiency
The neurologic findings distinguish this from isolated folate deficiency.
Pattern 3: Macrocytosis Without Neurologic Findings
A patient with heavy alcohol use has fatigue, glossitis, macrocytosis, elevated homocysteine, and normal methylmalonic acid.
Most likely diagnosis: Folate deficiency
Remember to exclude coexisting B12 deficiency before treating with folate alone.
Pattern 4: Low Iron but High Ferritin
A patient with rheumatoid arthritis has normocytic anemia, low serum iron, low TIBC, and elevated ferritin.
Most likely diagnosis: Anemia of chronic inflammation
Iron is present in storage but is not being made adequately available for erythropoiesis.
Pattern 5: Isolated Low Platelet Count
A patient develops petechiae and easy bruising after a viral illness. The platelet count is low, but hemoglobin, white blood cells, PT, and aPTT are normal.
Most likely diagnosis: Immune thrombocytopenia
Pattern 6: Thrombocytopenia With Schistocytes
A patient has confusion, renal dysfunction, anemia, thrombocytopenia, elevated LDH, and schistocytes.
Most concerning diagnosis: Thrombotic thrombocytopenic purpura
This is an emergency.
Pattern 7: Bleeding With Prolonged PT and aPTT
A critically ill patient with sepsis develops bleeding from intravenous sites, thrombocytopenia, prolonged PT and aPTT, elevated D-dimer, and low fibrinogen.
Most likely diagnosis: Disseminated intravascular coagulation
Common Hematology Mistakes to Avoid
Mistake 1: Calling Every Macrocytic Anemia a Vitamin Deficiency
Macrocytosis may also occur with:
- Alcohol use
- Liver disease
- Hypothyroidism
- Bone marrow disorders
- Reticulocytosis
- Certain medications
Use the clinical history, peripheral smear, vitamin studies, thyroid testing, liver studies, and reticulocyte count to narrow the diagnosis.
Mistake 2: Assuming a Normal Ferritin Excludes Iron Deficiency
Ferritin can rise during inflammation. A patient with inflammatory disease may have iron deficiency despite a ferritin value that appears normal.
Mistake 3: Giving Folic Acid Before Excluding B12 Deficiency
Folate can improve the anemia while neurologic damage from B12 deficiency continues.
Mistake 4: Diagnosing ITP Without Reviewing the Peripheral Smear
Platelet clumping can create a falsely low automated count. Schistocytes may indicate a much more dangerous process.
Mistake 5: Treating the Laboratory Number Instead of the Patient
A platelet count, hemoglobin level, PT, or aPTT must be interpreted alongside:
- Symptoms
- Active bleeding
- Hemodynamic status
- Rate of change
- Pregnancy status
- Comorbid conditions
- Medications
- Planned procedures
- Overall clinical appearance
Final Board-Exam Takeaways
Before your exam, make sure you can immediately recognize the following patterns:
Iron-Deficiency Anemia
Low ferritin + low iron + high TIBC + low transferrin saturation
Anemia of Chronic Inflammation
Low iron + normal or high ferritin + low or normal TIBC
Vitamin B12 Deficiency
Macrocytosis + elevated MMA + elevated homocysteine ± neurologic symptoms
Folate Deficiency
Macrocytosis + normal MMA + elevated homocysteine + no characteristic neurologic deficits
Immune Thrombocytopenia
Isolated thrombocytopenia + normal PT and aPTT
Disseminated Intravascular Coagulation
Low platelets + prolonged PT and aPTT + elevated D-dimer + low fibrinogen
TTP
Thrombocytopenia + microangiopathic hemolytic anemia + schistocytes ± neurologic or renal abnormalities
Warfarin
Monitor PT/INR
Unfractionated Heparin
Monitor aPTT or anti-Xa according to the treatment protocol
You Can Master Hematology
Hematology questions become much easier once you recognize that they are built around a limited number of recurring patterns.
Do not try to memorize every blood disorder. Start with:
- The MCV
- The reticulocyte response
- Iron studies
- Vitamin B12 and folate markers
- The platelet count
- PT, INR, and aPTT
- The patient’s symptoms and clinical history
Then ask yourself:
Is the problem caused by inadequate production, blood loss, red blood cell destruction, platelet destruction, or abnormal coagulation?
That single question can help you organize even a complicated vignette.
Every laboratory pattern you master brings you one step closer to passing your FNP boards and practicing with confidence.
Ready to Put Your Knowledge to the Test?
Reading a hematology review is only the beginning. The best way to build board-day confidence is to practice applying these concepts to realistic clinical vignettes.
The FNP Review provides comprehensive board-preparation resources, detailed clinical teaching, readiness tracking, and thousands of practice questions designed to help future nurse practitioners identify their weak areas, strengthen clinical reasoning, and approach the AANP or ANCC examination with confidence.
Study the patterns. Practice the questions. Trust your preparation. Let’s pass the FNP boards.
Educational disclaimer: This article is intended for educational and board-review purposes. Laboratory reference ranges, evaluation strategies, and treatment decisions may vary according to the patient, laboratory, clinical setting, and current professional guidelines.